RALEIGH, N.C., Dec. 3, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced the hiring of David Acheson as Vice President of Sales and Managed Markets. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) David joins BDSI with over 18 years of pharmaceutical and biotech sales and commercial experience. David will oversee the sales and managed markets support behind the anticipated launch of BUNAVAIL in 2014 as well as both current and future commercial partnerships. David's most recent relevant experience was leading the strategy and full build out and deployment of the sales organization for Pacira Pharmaceuticals Inc., an emerging specialty pharmaceutical company focused on the clinical and commercial development of products in the post-surgical pain market, where he played an instrumental role in the successful introduction of Exparel in 2012. Most recently, David was with CSL Behring as the National Director of Sales, Immunology and Pulmonary for two specialty teams focused in rare and orphan diseases. "We are extremely fortunate to have someone with David's talent and energy join our management team during this exciting and evolutionary phase of our company as we progress from a research and development focused company to a broader commercial entity," said Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI. "The timing of David's hiring is significant as we finalize our commercial plans for BUNAVAIL over the next several months. In parallel with our partnering discussions, we are making the appropriate plans to also launch BUNAVAIL. Regardless of which pathway we ultimately determine provides the best opportunity for the long term success of BUNAVAIL and BDSI's other products, David will oversee the sales and managed markets effort." David's pharmaceutical and biotech career began with Roche Pharmaceuticals where he worked as a Sales Representative, Medical Center Representative and Division Sales Manager. After five years in the hospital and oncology supportive care arena at Roche, David joined MedPointe/Meda Pharmaceuticals working his way through multiple areas of responsibility in sales as a District Sales Manager, Regional Sales Director and National Sales Director in the respiratory business. Also at Meda, David served as the National Sales Director, Pain and Supportive Care Team, and was responsible for building a full pain and oncology supportive care division of the company from scratch, deploying a full sales team as well as operational needs within the company. David has experience in a number of complex markets such as pain, palliative care, immunotherapy and orphan disease state products, many of which afforded him a great deal of involvement in the equally complex managed markets settings, developing and executing payer strategies as well as partnerships at the distribution and channel level. David has worked in collaborative partnerships and has significant experience working with contract sales organizations.